437 related articles for article (PubMed ID: 23756865)
1. Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells.
Carbajo-Pescador S; Ordoñez R; Benet M; Jover R; García-Palomo A; Mauriz JL; González-Gallego J
Br J Cancer; 2013 Jul; 109(1):83-91. PubMed ID: 23756865
[TBL] [Abstract][Full Text] [Related]
2. Suppression of STAT3 and HIF-1 alpha mediates anti-angiogenic activity of betulinic acid in hypoxic PC-3 prostate cancer cells.
Shin J; Lee HJ; Jung DB; Jung JH; Lee HJ; Lee EO; Lee SG; Shim BS; Choi SH; Ko SG; Ahn KS; Jeong SJ; Kim SH
PLoS One; 2011; 6(6):e21492. PubMed ID: 21731766
[TBL] [Abstract][Full Text] [Related]
3. Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling.
Liu P; Atkinson SJ; Akbareian SE; Zhou Z; Munsterberg A; Robinson SD; Bao Y
Sci Rep; 2017 Oct; 7(1):12651. PubMed ID: 28978924
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2-signal transducer and activator of transcription 3 pathway.
Liu X; Gao X; Zhang W; Zhu T; Bi W; Zhang Y
IUBMB Life; 2018 Jan; 70(1):81-91. PubMed ID: 29281186
[TBL] [Abstract][Full Text] [Related]
5. ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo.
Moser C; Lang SA; Mori A; Hellerbrand C; Schlitt HJ; Geissler EK; Fogler WE; Stoeltzing O
BMC Cancer; 2008 Jul; 8():206. PubMed ID: 18651980
[TBL] [Abstract][Full Text] [Related]
6. HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas.
Gray MJ; Zhang J; Ellis LM; Semenza GL; Evans DB; Watowich SS; Gallick GE
Oncogene; 2005 Apr; 24(19):3110-20. PubMed ID: 15735682
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma.
Chai ZT; Kong J; Zhu XD; Zhang YY; Lu L; Zhou JM; Wang LR; Zhang KZ; Zhang QB; Ao JY; Wang M; Wu WZ; Wang L; Tang ZY; Sun HC
PLoS One; 2013; 8(10):e77957. PubMed ID: 24194905
[TBL] [Abstract][Full Text] [Related]
8. Guggulsterone inhibits angiogenesis by blocking STAT3 and VEGF expression in colon cancer cells.
Kim ES; Hong SY; Lee HK; Kim SW; An MJ; Kim TI; Lee KR; Kim WH; Cheon JH
Oncol Rep; 2008 Dec; 20(6):1321-7. PubMed ID: 19020709
[TBL] [Abstract][Full Text] [Related]
9. Rhaponticin decreases the metastatic and angiogenic abilities of cancer cells via suppression of the HIF‑1α pathway.
Kim A; Ma JY
Int J Oncol; 2018 Sep; 53(3):1160-1170. PubMed ID: 30015877
[TBL] [Abstract][Full Text] [Related]
10. HGF regulates VEGF expression via the c-Met receptor downstream pathways, PI3K/Akt, MAPK and STAT3, in CT26 murine cells.
Matsumura A; Kubota T; Taiyoh H; Fujiwara H; Okamoto K; Ichikawa D; Shiozaki A; Komatsu S; Nakanishi M; Kuriu Y; Murayama Y; Ikoma H; Ochiai T; Kokuba Y; Nakamura T; Matsumoto K; Otsuji E
Int J Oncol; 2013 Feb; 42(2):535-42. PubMed ID: 23233163
[TBL] [Abstract][Full Text] [Related]
11. The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1α in liver cancer cells.
Fu C; An N; Liu J; A J; Zhang B; Liu M; Zhang Z; Fu L; Tian X; Wang D; Dong JT
J Biol Chem; 2020 May; 295(20):7060-7074. PubMed ID: 32277050
[TBL] [Abstract][Full Text] [Related]
12. Luteolin inhibits angiogenesis of the M2‑like TAMs via the downregulation of hypoxia inducible factor‑1α and the STAT3 signalling pathway under hypoxia.
Fang B; Chen X; Wu M; Kong H; Chu G; Zhou Z; Zhang C; Chen B
Mol Med Rep; 2018 Sep; 18(3):2914-2922. PubMed ID: 30015852
[TBL] [Abstract][Full Text] [Related]
13. miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells.
Cascio S; D'Andrea A; Ferla R; Surmacz E; Gulotta E; Amodeo V; Bazan V; Gebbia N; Russo A
J Cell Physiol; 2010 Jul; 224(1):242-9. PubMed ID: 20232316
[TBL] [Abstract][Full Text] [Related]
14. Melatonin restricts the viability and angiogenesis of vascular endothelial cells by suppressing HIF-1α/ROS/VEGF.
Cheng J; Yang HL; Gu CJ; Liu YK; Shao J; Zhu R; He YY; Zhu XY; Li MQ
Int J Mol Med; 2019 Feb; 43(2):945-955. PubMed ID: 30569127
[TBL] [Abstract][Full Text] [Related]
15. Ectopic decorin expression up-regulates VEGF expression in mouse cerebral endothelial cells via activation of the transcription factors Sp1, HIF1alpha, and Stat3.
Santra M; Santra S; Zhang J; Chopp M
J Neurochem; 2008 Apr; 105(2):324-37. PubMed ID: 18021292
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
[TBL] [Abstract][Full Text] [Related]
17. Pomolic acid suppresses HIF1α/VEGF-mediated angiogenesis by targeting p38-MAPK and mTOR signaling cascades.
Park JH; Yoon J; Park B
Phytomedicine; 2016 Dec; 23(14):1716-1726. PubMed ID: 27912873
[TBL] [Abstract][Full Text] [Related]
18. Suppression of VEGF expression through interruption of the HIF‑1α and Akt signaling cascade modulates the anti‑angiogenic activity of DAPK in ovarian carcinoma cells.
Park ST; Kim BR; Park SH; Lee JH; Lee EJ; Lee SH; Rho SB
Oncol Rep; 2014 Feb; 31(2):1021-9. PubMed ID: 24337450
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin.
Dal Monte M; Martini D; Ristori C; Azara D; Armani C; Balbarini A; Bagnoli P
Naunyn Schmiedebergs Arch Pharmacol; 2011 Jun; 383(6):593-612. PubMed ID: 21523559
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species regulate FSH-induced expression of vascular endothelial growth factor via Nrf2 and HIF1α signaling in human epithelial ovarian cancer.
Zhang Z; Wang Q; Ma J; Yi X; Zhu Y; Xi X; Feng Y; Jin Z
Oncol Rep; 2013 Apr; 29(4):1429-34. PubMed ID: 23404377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
